Last updated on February 2019

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)


Brief description of study

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

Clinical Study Identifier: NCT02953704

Contact Investigators or Research Sites near you

Start Over

MOST Study (Incyte Corporation)

Covington, LA United States
8.37miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.